Compass, Inc. heads into its May 14 Q1 2026 earnings print carrying one of the strongest EPS momentum readings in the market — yet short sellers have quietly begun rebuilding positions over the past week.
The most striking feature of the positioning picture is what happened last week. Short interest climbed roughly 7% in a single week to 7.3% of free float — partially unwinding a larger retreat that had seen shorts cut exposure by 14% over the prior month. That month-long de-risking coincided with the stock's 17% rally to $8.36, but the week-on-week re-entry suggests some bears are not convinced the move holds. Borrowing the stock remains cheap at 0.55% annually, with minimal change over the week. Availability in the lending pool is ample, meaning there is no mechanical squeeze pressure threatening open short positions heading into the print. Options, however, point the other way: the put/call ratio climbed to 0.25 — more than two standard deviations above its 20-day mean of 0.18 — suggesting a pickup in hedging demand even as the ratio remains low in absolute terms.
The recent earnings history sharpens the stakes. The last print, delivered on May 5, sent COMP up more than 30% on the day and an additional 18% over the following five days — the kind of reaction that explains both the bulls adding exposure and bears rebuilding short positions ahead of the next release. Factor scores reinforce the bull case: EPS momentum ranks at the 99th percentile on both a 30-day and 90-day basis, and forward EPS growth year-on-year ranks at the 98th percentile. On the bear side, the stock has gained 15% in a week while peers including and added only 4% and 2.5% respectively — and actually fell 8% over the same stretch — suggesting may have run ahead of its sector.
The analyst debate captures this split cleanly. Targets have been converging toward the $12–$13 range, with Morgan Stanley raising to $12.50 earlier this month while maintaining its neutral Equal-Weight stance. UBS and Barclays both trimmed targets in April — UBS cut from $17 to $12 — while keeping Buy and Overweight ratings. Wells Fargo is more cautious at $9, essentially in line with where the stock was trading before last week's jump. The mean target of roughly $13.17 implies about 57% upside from current levels. Bulls point to a 37,000-strong agent network, potential for EBITDA to double in coming years, and high-teens gross transaction value growth. Bears flag the ongoing legal dispute with ZG over Private Exclusives listings, a 3.2% residential market share, and local concentration risk from the House acquisition.
Institutional holders are broadly adding: Vanguard, FMR, and BlackRock all increased positions in the most recent reporting period, and T. Rowe Price added nearly 9 million shares. Insider activity is routine — award-and-sell programs by the CFO and CLO — with CEO Robert Reffkin selling $7.7 million in February at $11.98, well above current levels. The May 14 print is therefore less about whether momentum is real and more about whether the company can sustain a margin trajectory that justifies a stock re-rating after a month-long 17% rally that the rest of the sector did not share.
See the live data behind this article on ORTEX.
Open COMP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
